Further molecular mechanisms and rescue experiments confirmed that high expression of PLCG2 promoted CRC cell proliferation, epithelial-mesenchymal transition (EMT), migration, and invasion and inhibited apoptosis by activating the Akt-mTOR signaling pathway. This evidence concerns the gene PLCG2 and colorectal carcinoma.